drugset / Trial / NCT03914131

Clinical Trial Scheme of Xinnaoning Capsule

NCT03914131 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a randomized, double-blind, parallel-controlled, multicenter clinical study to evaluate the efficacy and safety of Xinnaoning capsule in the treatment of chronic stable angina pectoris (Qi stagnation and blood stasis syndrome).

Timeline

Start
2018-05-15
Primary completion
2019-12
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Xinnaoning Capsule Unknown 3 unknown Oral